I RA- forsøgne I- IV opnåede Humira- behandlede patienter statistisk signifikant ACR 20 - og 50 - respons sammenlignet med placebo allerede én til to uger efter behandlingsstart.
In RA studies I-IV, Humira-treated patients achieved statistically significant ACR 20 and 50 responses compared to placebo as early as one to two weeks after initiation of treatment.